Keywords: Mitochondria Parkinson's disease ER-mitochondria tethering Mitofusin Parkin PINK1 Ubiquitination ER-mitochondria synthetic tether Drosophila model of PD A B S T R A C T Parkin, an E3 ubiquitin ligase and a Parkinson's disease (PD) related gene, translocates to impaired mitochondria and drives their elimination via autophagy, a process known as mitophagy. Mitochondrial pro-fusion protein Mitofusins (Mfn1 and Mfn2) were found to be a target for Parkin mediated ubiquitination. Mfns are transmembrane GTPase embedded in the outer membrane of mitochondria, which are required on adjacent mitochondria to mediate fusion. In mammals, Mfn2 also forms complexes that are capable of tethering mitochondria to endoplasmic reticulum (ER), a structural feature essential for mitochondrial energy metabolism, calcium (Ca 2+ ) transfer between the organelles and Ca 2+ dependent cell death. Despite its fundamental physiological role, the molecular mechanisms that control ER-mitochondria cross talk are obscure. Ubiquitination has recently emerged as a powerful tool to modulate protein function, via regulation of protein subcellular localization and protein ability to interact with other proteins. Ubiquitination is also a reversible mechanism, which can be actively controlled by opposing ubiquitination-deubiquitination events. In this work we found that in Parkin deficient cells and parkin mutant human fibroblasts, the tether between ER and mitochondria is decreased. We identified the site of Parkin dependent ubiquitination and showed that the non-ubiquitinatable Mfn2 mutant fails to restore ER-mitochondria physical and functional interaction. Finally, we took advantage of an established in vivo model of PD to demonstrate that manipulation of ER-mitochondria tethering by expressing an ER-mitochondria synthetic linker is sufficient to rescue the locomotor deficit associated to an in vivo Drosophila model of PD.
Introduction
Parkinson's disease (PD) is the second most common neurodegenerative disease, for which there is no cure. Although the exact cause of most cases is unknown, both environmental and genetic factors are implicated in the onset of the disease. In the last few years, a number of genes have been identified, which cause inherited PD and account for ∼10% of PD cases [1] . Some of these genes encodes for proteins that are either expressed in the mitochondria or targeted to the mitochondria upon stressful condition. Indeed, mitochondrial dysfunction is strongly implicated in the aetiology of the disease and impaired mitochondria are found in animal and cell models of PD [2] .
Mitochondria form a tubular, reticulated network which shape is controlled by opposing fusion and fission events [3] . The Mitofusins 1 and 2 (Mfn1 and Mfn2) are conserved dynamin-like GTPases, composed of a large cytosolic GTPase domain, an HR1 domain, a double transmembrane domain embedded in the outer mitochondrial membrane (OMM) and a second HR2 domain (HR2) [4] . Mfn1 mediate mitochondrial fusion of OMM in coordination with OPA1, which mediates the fusion of IMM [5, 6] . While Mfn1 seems primarily involved in organellar docking and fusion, Mfn2 is enriched at contact sites between ER and mitochondria called MERC (mitochondria-ER contact sites) where it regulates organelles tethering [7] [8] [9] [10] . MERCs are sites of dynamic physical and functional interaction that regulate phospholipid https://doi.org/10.1016/j.phrs.2018.09.006 Received 2 March 2018; Received in revised form 4 July 2018; Accepted 6 September 2018
Parkin selectively ubiquitinates mammalian Mfn1 and Mfn2. Accordingly, lack of Parkin (or PINK1 which operates upstream Parkin in the same pathway) [23] [24] [25] [26] results in increased amount of the steady state levels of dMfn and a reduction of dMfn ubiquitination forms [19] .
In this work we show that a post-translational modification (PTM), e.g. a Parkin dependent ubiquitination, plays an indispensable role in the formation of ER-mitochondria contacts sites via Mfn2. Moreover, we demonstrate that in vivo manipulation of ER-mitochondria tethering by expressing an ER-mitochondria synthetic linker is sufficient to rescue the locomotor deficits associated to an in vivo Drosophila model of PD.
Results

Parkin regulates ER-mitochondria contacts
In S2R+ Drosophila cells overexpression of Flag tagged dMfn allows the identification of four bands by western blotting (WB). As previously shown, the smaller molecular weight band (∼90KDa) corresponds to unmodified dMfn whereas the upper bands (∼100KDa, 130KDa and 140KDa) correspond to monoubiquitinated and multiubiquitinated forms of dMFN, respectively [19] . A similar pattern of ubiquitination was also previously described for Mfn2 in Hela cells [21] , human neuroblastoma cells SH-SY5Y [22] and for the yeast Mfn homologue, antibody (Abcam). WB analysis was performed with antibodies α-Mfn2 (Abnova) or α-HA (cell signaling) on the pulled down samples. (-) identify samples incubated without antibody (negative control). Inputs represent 10% of the protein lysates and IP eluate 100% of the protein lysates (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.).
fuzzy onions (Fzo1) [27] . This pattern of ubiquitination is PINK1/ Parkin dependent. Accordingly, in the absence of PINK1 or Parkin, steady state levels of dMfn are increased and the pattern of ubiquitination is abolished [19] . Considering that dMfn in the fruit fly includes both promotion of fusion and ER-mitochondria crosstalk [28] and the role of Mfn2 in ER-mitochondria tethering [7] [8] [9] [10] 29] , we investigated the degree of tethering between ER and mitochondria upon Parkin downregulation, i.e. in a condition where dMfn ubiquitination is impaired. Volume rendered 3D reconstruction of z-axis stacks of confocal images of fluorescent-tagged mitochondria and ER has been previously used to measure contact sites between the two organelles [12] . We transfected S2R + fly cells with expression vectors encoding mitochondrial and endoplasmic reticulum fluorescent marker (mDsRed and ER-GFP respectively) and upon treatment with Ctrl or Parkin dsRNA to specifically knock down Parkin. We then measured the degree of tethering by using Mander's coefficient of co-localization upon volume-rendered 3D reconstruction of z-axis stacks of confocal images. In such 3D reconstruction, the overlap between red and green fluorescence (yellow spots) represents area of organelle tethering. We found a clear decrease in ER-mitochondria interaction in Parkin downregulating cells ( Supplementary Fig. 1A -B). To consolidate these data, we performed electron microscopy (EM) analysis on control and parkin downregulating cells and measured the average distance between mitochondria and the juxtaposing ER. We found a significant increase in ER-mitochondria distance (i.e. MERCs width) in parkin deficient S2R + cells ( Supplementary Fig. 1C -D) and an overall decrease in the average number of ER-mitochondria contacts per mitochondria (Supplementary Fig. 1E ) compared to control cells. To validate our findings, we performed the same measurement in a different cell type. MEFs cells, treated with scramble (Ctrl) or Parkin siRNA, were transfected with mitochondrial and endoplasmic reticulum fluorescent marker (mRFP and ER-YFP respectively). We observed a clear reduction in ERmitochondria contacts in Parkin downregulating cells (Fig. 1A-B) , as previously showed [14] . To consolidate these data, we also measured ER-mitochondria proximity by using a modified FRET-based indicator of ER-mitochondria proximity named FEMP [29] . This sensor is targeted to the mitochondrial outer membrane (OMM) (targeting sequence mAKAP1 connected to YPF fluorescent protein) and ER (targeting sequence Sac1 connected to CFP fluorescent protein) and contains a selfleaving Tav2 A peptide, which undergoes autocleavage releasing YFP and CFP. This sensor is designed to guarantee almost equimolar expression of YFP on the mitochondrial outer membrane (OMM) and of the Cyan fluorescent protein (CFP) on the ER surface. FRET intensity is inversely proportional to the distance between the two fluorophores, thus allowing a quantitative measurement of organelles proximity. In the FEMP probe, OMM and ER targeting sequence are coupled with the two components of the FKBP-FRP heterodimerization system that allows covalent linkage between ER and mitochondria upon rapamycin administration. ER-mitochondria juxtaposition can therefore be correlated to FRET intensity and rapamycin treatment allows heterodimerization between adjacent FKBP and FRB domains to maximize energy transfer. We analyzed FRET ratio changes in MEFs coming from conditional Parkin KO mice in which Parkin expression can be deleted upon expression of Cre recombinase by recombining loxP sites ad hoc inserted in exon 7 (Parkin Flx/Flx mice) [30, 31] . Transfection of MEFs with pcDNA 3.1-Cre leads to an obvious decrease in Parkin mRNA as compared to pcDNA 3.1 transfected cells ( Supplementary Fig. 1F ). We transfected Parkin Flx/Flx MEFs with pcDNA 3.1 (CTRL) or pcDNA 3.1-Cre (CRE) and in combination with the FEMP probe. We measured a decrease in the FEMP FRET ratio in Parkin downregulating cells further sustaining the knowledge that ER-mitochondria tethering is reduced in Parkin downregulating conditions (Fig. 1C) . We thought to extend these data and investigate the pattern of Mfn2 ubiquitination in these conditions. (Fig. 1D) . Thus, also in a mammalian cell type, impaired Mfn2 ubiquitination correlates to defective ER-mitochondria tethering.
These results sustain the hypothesis that aberrant ER-mitochondria interaction occurs in the absence of parkin, a condition that leads to impaired Mfn2 ubiquitination.
CMT type 2A disease-associated MFN mutants are not ubiquitinated and are incompetent in promoting ER-mitochondria interaction
Ablation of Mfn2 in mice is embryonically lethal and Mfn2 mutations in humans are associated with the onset of Charcot-Marie-Tooth neuropathy type 2A (CMT2A), an hereditary axonal peripheral neuropathy with patients developing early and severe motor disabilities that in the most severe cases constrict them to wheelchair [32, 33] . The most frequent mutation in Mfn2 found in CMT2 A patients, R94Q, cannot restore ER-mitochondria contacts in Mfn2 KO MEFs [8] . We looked at the pattern of ubiquitination in S2R+ Drosophila cells upon expression of Flag-tagged form of MFN R94Q mutant and two additional CMT type 2 A disease-associated MFN mutations (P251 A and R280H, respectively) and we found a complete loss of the ubiquitinated MFN forms in S2R+ Drosophila cells ( Supplementary Fig. 2 ). To examine whether this was also the case in mammalian cells, we looked at the pattern of Mfn2 ubiquitination in Mfn2 KO MEFs transiently reconstituted with either wild type Mfn2 or mutants Mfn2 P251A and Mfn2
R280H
. Western blotting analysis of Mfn2 by using anti Mfn2 antibody revealed a single band of the predicted size of Mfn2 (∼86 KDa) ( Fig. 2A) . Immunoprecipitates of wt Mfn2, Mfn2 P251A and Mfn2 R280H were prepared by using anti Mfn2 antibody and WB analysis was performed with antibody against Ubiquitin on the pulled down samples to identify ubiquitinated forms of Mfn2. We observed a clear reduction of Mfn2-Ub in all CMT type 2 A disease-associated Mfn2 mutants ( Fig. 2A) . Remarkably, we observed a reduction in ER-mitochondria contacts in Mfn2 KO MEFs reconstituted with Mfn2 P251A or Mfn2 R280H as compared to wt Mfn2 ( Fig. 2B-C) .
These results further sustain the intriguing hypothesis that ubiquitination of Mfn2, rather than its steady state levels, is an essential prerequisite for ER-mitochondria tethering.
Ubiquitination of Lysine 416 in the HR1 Mfn2 domain control physical and functional ER-mitochondria interaction
Our results indirectly suggest that lack of MFN ubiquitination correlates to impaired ER-mitochondria interaction. With that in mind, we conducted a bioinformatics study to identify the potential Mfn2 site that could be ubiquitinated by Parkin. Mfn1 and Mfn2 are anchored at the outer mitochondrial membrane and have N-and C-terminal domains that protrude into the cytosol. At the N-terminus, there is a GTP binding domain, followed by a hydrophobic heptad repeat region (HR1) and a transmembrane domain (TM), which allows anchorage to the outer membrane. At the C-terminal, there is a second hydrophobic heptad repeat (HR2) [4] . This protein structure is highly conserved between different species [4] , although an interesting work recently challenged this model, providing functional evidences that mammalian Mfns are single-spanning outer membrane proteins with an N out -C in orientation [34] . Nevertheless, a number of publications reported an almost identical pattern of ubiquitination for yeast homologue fuzzy onion (fzo1) Pharmacological Research 138 (2018) [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] (caption on next page) [27, 35] , fly homologue Marf/dMfn [19] and human Mfn2 [21, 35, 36] . We therefore thought it was reasonable to hypothesis that the site of ubiquitination may be evolutionary conserved among species. Indeed, multiple sequence alignments using MultAlin revealed a high degree of homology between human, mouse and dMfn protein sequence. This phylogenic analysis identified twenty Lysine residues (K) that are conserved between these species (arrowheads Supplementary  Fig. 3A-B) . Two independent studies also identified by using a mass spectrometry approach, a number of Lysine residues that are ubiquitinated upon Parkin overexpression [37, 38] . We matched the residues identified by these works with ours, and we identified six Lysine residues that are likely to represent good candidates for Parkin-dependent ubiquitination of Mfn2 (Fig. 3A) . As illustrated, K36 and K84 are located at the N-terminal of the protein, before the GTPase domain, K355 is positioned between the GTPase and HR1 domain, K416 is within the HR1 domain and K732 and K737 are in the HR2 domain (Fig. 3B) . We proceeded by generating non-ubiquitinatable mutants for each domain, and in this case for K36, K416 and K737 by substituting Lysine with Arginine (R), a common procedure to impair ubiquitination [39] . We expressed Flag-tagged mutants dMfn K36R , dMfn K416R and dMfn K737R in 
Mfn2
R280H p value = 0.0001) (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.). ] mit from nine independent experiments where Mfn2 KO MEFs were transfected with the indicated plasmids and mtAEQ. (G) Average ± SEM of peak [Ca 2+ ] mit in nine independent experiments performed as in G (Unpaired Two-tailed t-test p value = 0.0186) (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.).
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S2R+ Drosophila cells. Western blotting analysis of dMfn by using anti Flag antibody revealed a single band of the predicted size of unmodified dMfn (∼90 KDa) and a number of higher molecular weight bands which corresponds to mono and poly ubiquitinated forms of dMfn, as previously described [19] . Interestingly, expression of non-ubiquitinatable mutant dMfn K416R failed to reproduce the predicted pattern of ubiquitination ( Supplementary Fig. 3C ). Confocal microscopy analysis confirmed the mitochondrial subcellular localization of mutant dMfn K416R ( Supplementary Fig. 3D 
ER-mitochondria physical and functional interaction is impaired in parkin mutant fibroblasts
Our results strongly indicate a causal link between impaired ubiquitination of Mfn2 and physical and functional ER-mitochondria miscommunication, specifically in the context of Parkin deficiency. Although the exact cause for dopaminergic neurons loss in PD patients is unknown, these cells are highly susceptible to perturbations in Ca 2+ homeostasis and lipid transfer, both affected upon impaired ER-mitochondrial juxtaposition [40, 41] . An elegant study has shown that the (A) Representative images of confocal acquisition of human fibroblast of the indicated genotypes generated from skin biopsy loaded with 1 μ M of Tetramethylrhodamine methyl ester (TMRM). The 60 z-axis images separated by 0.2 μm were analysis using Volocity 6.3 software, to obtain analysis of the mitochondrial volume, surface area (B) (unpaired Two-tailed t-test p value = 0.0655), skeletal length (C) (unpaired Two-tailed t-test P value = 0.0401) and the aspect ratio (D) (unpaired Two-tailed t-test P value = 0.05) calculated as described in materials and methods. Graph bars represents mean ± SEM of n = 3 replicates. (E) Human fibroblast of the indicated genotypes were infected with the FEMP probe. FRET ratio (ΔR/R) was calculated as described in materials and methods. Graph bar indicates mean ± SEM. n = 3; unpaired Two-tailed t-test p value = 0.0o65 (F) Representative TEM images of human fibroblast of the indicated genotypes. (G) Mean ± SEM of mitochondria-ER distance calculated in four independent experiments as in F. Unpaired Two-tailed t-test p value = 0.0074. n = 3. (H) Mean ± SEM of [Ca 2+ ] mit from four independent experiments of human fibroblast of the indicated genotypes, transfected with mtAEQ. Cells were perfused with a mixture of 0.1 μM ATP and 0.1 μM histamine. (I) Average ± SEM of peak [Ca 2+ ] mit in four independent experiments performed as in H. Unpaired Two-tailed t-test p value < 0.0001.
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vulnerability of dopaminergic neurons depends on their reliance on a specific subtype of voltage dependent L-type Ca 2+ channels that require Ca 2+ to maintain their autonomous pacemaking activity and which expression is age dependent. Blocking these channels has a neuroprotective effect because it allows neurons to "rejuvenile" and go back to a Ca 2+ independent mechanism to generate their pacemaking activity [42] . This work highlighted the importance of age-dependent Ca 2+ homeostasis regulation for the survival of dopaminergic neurons, and led us to the intriguing hypothesis that ER-mitochondria miscommunication might also add to the disease onset. With that in mind, we conducted a study to analyse mitochondria morphology and ERmitochondria physical and functional interaction in a characterized clinical case of PD patient associated with a parkin-mutant. We used four sets of techniques, namely live cell confocal imaging of organelle morphology, electron microscopy, FRET based measurement of ERmitochondria physical proximity and Aequorin based measurement of ER-mitochondria Ca 2+ transfer, to assess the shape of mitochondria, and ER-mitochondria physical and functional interaction in fibroblasts coming from skin biopsy of parkin patient with compound heterozygous (R275 W and exon 3 deletion) parkin mutations. We started by investigating mitochondrial morphology in primary fibroblasts culture coming from skin biopsy of parkin patient and age matched control. Primary fibroblasts were loaded with membrane potential independent mitochondrial dye Mitotracker red (Molecular Probes) that allows qualitative in vivo imaging assessment of mitochondria morphology by confocal microscopy (Fig. 4A ). Mitochondria morphology was analysed by Volocity software (PerkinElmer) upon three-dimensional (3D) reconstruction and volume rendering of confocal stacks. Mitochondrial surface area (Fig. 4B ), skeletal length ( 4B ) were measured from three independent clones coming from parkin patient skin biopsy and age matched control. We found increased mitochondrial surface area as well as mitochondrial skeletal length and AR in cells coming from parkin mutant patient compared to control ( Fig. 4B-D) , clearly indicating altered mitochondrial morphology in primary fibroblasts deriving from parkin patient. We next measured ERmitochondria proximity by using the FEMP probe as previously done [29] . Parkin patient cells expressing the FEMP probe measured a decrease in the FEMP FRET ratio compared to control cells, supporting the knowledge that ER-mitochondria distance is increased in parkin patient (Fig. 4E) . To extend these observations we compared our previous finding with electron microscopy (EM) analysis of control and parkin fibroblasts. We measured the average distance between mitochondria and the juxtaposing ER and we found a significant increase in ER-mitochondria distance (i.e. MERCs width) in parkin deficient patient cells ( Fig. 4F-G we investigated the effect of expressing an ER-mitochondria synthetic linker in Drosophila PINK1 KO, a well-established in vivo model of PD that is deficient for Parkin function [19, 45] . This is also presumably a good in vivo model of aberrant Ca 2+ homeostasis, since a number of studies have previously shown impaired Ca 2+ handling in cellular models lacking PINK1 [46, 47] . We generated two Drosophila transgenic lines that allow visualising in vivo in the adult wing ER-mitochondria contacts through expression of a synthetic tether construct driven by a neuron-specific driver. The construct was created by Csordás et al. [43] and encodes monomeric red fluorescent protein (mRFP) fused to the OMM-targeting sequence (MTS) of mAKAP1 at the N-terminus and fused to the ER-targeting sequence (ERTS) of yUBC6 at the C-terminus (Supplementary Fig. 5A ). We cloned the construct for the synthetic linker into a fly vector and generated two "tethering" lines by random insertion in a wild type (white1118) background under expression of the GAL4-UAS system. These lines expressed mild (TM, Tether Mild) to high (TH, Tether High) levels of the tethering construct. We expressed the TM "tethering" line in wild type (white1118) − and PINK1 mutant (KO) flies (PINK1 B9 ). To assess that the construct was appropriately expressed, and to visualize ex vivo ER-mitochondrial contacts in the fly, we took advantage of a recently described model, which allows imaging of sensory neurons in the translucent fly wing [48] . We fixed flies of the desired age in PFA, detached the wing and measured ER-mitochondria contact sites by imaging at confocal microscope of the red fluorescent signal in the L1 vein neuron bundle. In order to activate neuronal expression of the UAS tether lines we crossed these lines with nSyb-Gal4 (neuronal Synaptobrevin) expressing flies. We observed well-defined and easily quantifiable red fluorescent spots throughout the L1 vein that perfectly matched the pattern seen when expressing only mito-GFP or ER-GFP in the wing neurons ( Supplementary Fig. 5B ). Interestingly, we observed a reduced expression of the tethering probe (i.e. reduction in the RFP signal) in PINK1 KO flies (Fig. 5A-B) , indicative of a previously described impairment in the mitochondrial protein import machinery of the PINK1 deficient flies [49] . Next we used a well-established locomotor assay to evaluate in vivo the physiological relevance of expressing the synthetic ER-mitochondria linker. In such assay, 10 flies for each strain were collected in a vertical plastic tube positioned with a line drawn at 6 cm from the bottom of the tube and under a light source. After tapping the flies to the bottom of the tube, the flies that successfully climbed above the mark after 10 s were counted (Fig. 5C ). As already reported, PINK1 B9 mutant (PINK1 KO) flies performed poorly in the climbing assay compared to wild type (Ctrl) flies (Fig. 5D) . Remarkably, climbing performance of PINK1 KO flies was significantly improved upon expression of the synthetic ER-mitochondria linker TM (Fig. 5D ), sustaining the hypothesis that in vivo genetic normalization of ER-mitochondria tethering is beneficial in ameliorating the locomotor impairment associated to PINK1 deficiency. Of note, expression of the TH (tether high) synthetic tethering construct resulted lethal in wild type but not in PINK1 KO background, where it did not ameliorate the climbing performance of PINK1 flies (Fig. 5E ) further corroborating the hypothesis that fine tuning ER-mitochondria interaction by expression of the synthetic linker has physiological implications in vivo. Intriguingly, TH expression did not impact eggs to pupae viability (Fig. 5F ), but impaired adults/pupae ratio (Fig. 5G) indicating an age dependent lethality that occurs when pupae become adults.
Discussion
Parkin, a protein which mutations have been linked to the onset of a rare autosomal recessive form of familiar PD, is an E3 ubiquitin ligase that belongs to the Ring-between-RING (RBR) type of E3 ubiquitin ligases, also known as RING/HECT hybrids [50] . By mediating the covalent attachment of the highly conserved 76-amino acid protein ubiquitin on target proteins, Parkin controls a fundamental posttranslational modification (PTM) that is required for proteasome-dependent protein degradation. Parkin is predominantly localized in the [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] cytosol, but it can translocate to depolarized mitochondria where it promotes polyubiquitination of outer mitochondrial membrane resident proteins, which is a prerequisite for mitochondria quality control or mitophagy, a well characterized cellular process that leads to the elimination of a selective subset of damaged mitochondria via autophagy [18] . In a number of cellular models, Parkin promotes the ubiquitination of Marf/dMfn (fly homologue of mammalian Mitofusins) [19] and both Mitofusin 1 (Mfn1) and Mitofusin 2 (Mfn2) [21, 22] . Ubiquitination of Mitofusins leads to proteasome-and p97-dependent degradation of the proteins [21] . However, recent studies reported proteosome-independent-mediated ubiquitinations by Parkin, which do not result in degradative ubiquitination. For example, in 2006 two groups independently observed that Parkin catalyzes the formation of multiple monoubiquitination in vitro [51, 52] . Additional study propounded that Parkin activation results in the formation of K63-linked ubiquitin chains, which does not results in decreased levels of the target protein [53] . Similarly it was demonstrated that Parkin can form linear ubiquitination of NF-κB essential modulator (NEMO) causing the activation of NF-κB pro-survival pathway [50] . All these observations suggest that Parkin may act like a multi-functions ubiquitin protein ligase capable of both mediating degradative ubiquitination (proteosomal or autophagy-dependent degradation) [ [60, 61] . Parkin targets Mitofusins, large GTPase proteins that are required on adjacent mitochondria to promote tethering and fusion of the outer mitochondria membrane. In mammals Mfn2 also regulates ER-mitochondrial tethering [7] [8] [9] [10] 29] . ER-mitochondria physical interaction is a structural feature that is indispensable for Ca 2+ cross talk, phospholipid biosynthesis, autophagosome formation, DRP1 mediated mitochondrial fission and a number of additional physiological signaling pathways that are essential for cell survival [12, 13, 40, [62] [63] [64] [65] . Starting from the observation that Parkin downregulation in MEFs results in transfer could be beneficial, we investigated the effect of expressing an ER-mitochondria synthetic linker in a well-established in vivo Drosophila model of PINK1 loss of function. PINK1 mutant (KO) flies have a very obvious phenotype characterized by male sterility, degeneration of thorax muscle, degeneration of dopaminergic neurons, locomotor defects, reduction in lifespan and mitochondrial dysfunction [23] [24] [25] . We demonstrated that expression of the mild tether (TM) induced a significantly improvement in the climbing performance of PINK1 KO flies, supporting the notion that ER-mitochondria cross talk normalization could be effective in ameliorating some of the phenotypes that are associated to PD neurodegeneration, and may hold substantial therapeutic implication for this disorder. Altogether, these results led us to envision a model where Parkin dependent ubiquitination of Mfn2 is required on healthy mitochondria to mediate ER-mitochondria crosstalk (Fig. 6(a) upper representation) . This model does not exclude the existence of a parallel stress induced pathways (like those generated by intoxicating substances), which promotes Parkin-dependent ubiquitination of Mfn2, and additional OMM resident proteins, to promote mitophagy (Fig. 6(b) lower representation).
Materials and methods
Cell culture
Drosophila S2R + cells grow at 25°C without CO 2 , as semi-adherent monolayer in tissue culture flasks. The complete medium for SR2+ cells is Schneider's Drosophila Medium (Gibco) containing 10% heatinactivated fetal bovine serum (FBS). Transfection was performed using Effectene Transfection Reagent (QIAGEN) following manufacturer instruction. 5 h after the transfection medium was removed and change with fresh medium and after 72 h the cells were used to the indicated experiments.
The mouse embryonic fibroblasts (MEFs) grow in Dulbecco's modified Eagle medium (DMEM) (Gibco) with addition of 1% penicillin/ streptomycin, 1% non-essential amino acids solution, L-glutammine and 10% FBS at 37°C with 5% CO 2 atmosphere.
Mfn2 KO MEFs were provided by Dr. Luca Scorrano, Department of Biology, University of Padova. Parkin Flx/Flx MEF were obtained from Dr.
Ted Dawson, Johns Hopkins University [31] . TransFectin™ Lipid Reagent (Bio-Rad) or GenJet™ In Vitro DNA Transfection Reagent (SignaGen laboratories) were used for the transfection following the manufacturer's instruction. The medium was changed after 5 h and the experiments performed after 24 h/48 h from the transfection. Human fibroblasts from skin biopsy were obtained from B.A., a 55-year old man who was diagnosed with PD at the age of 28 and presented an excellent response to a combination of levodopa and dopamine agonists until 2008. He then started complaining about motor fluctuations and involuntary movements and more recently developed pathological gambling, excessive impulsivity, aggressiveness and substance abuse (mainly cocaine). Cognitive testing in 2016 showed abnormalities in frontal executive and attention domains. His MRI revealed modest cortical and subcortical atrophy. Cells were grown in Dulbecco's modified Eagle medium (DMEM) (Gibco) with addition of 1% penicillin/streptomycin, 1% non-essential amino acids solution, Lglutammine and 10% FBS at 37°C with 5% CO 2 atmosphere. Cells were used between passage P = 4 to P = 7 and transfection was performed using Lipofectamine Transfection Reagent (Invitrogen) achieving a maximal efficiency of transfection of 5%. For calcium measurement experiments, human fibroblasts were seeded onto 13 mm-diameter glass coverslips and maintained at 37°C in a humidified incubator. After 24 h, cells were infected with lentiviral (LV) particles using the minimal dilution adequate for obtaining ≈70% of infected cells. Ca 2+ measurements were performed 96 h after plating as described.
HEK-293 T cells to generate Lentiviral (LV) particles were grown in Dulbecco's modified Eagle's medium/High-Glucose (Euroclone), supplemented with 10% fetal bovine serum (Euroclone), 100 U/ml penicillin and 100 μg/ml streptomycin (Euroclone), and maintained at 37•C in a humidified incubator with 5% CO 2 ] mit fluctuations analysis were performed by transducing human fibroblasts with a third generation lentivirus-based system that allow the expression of a chimeric construct encoding the Ca 2+ -probe aequorin (AEQ) tagged with the influenza virus hemagglutinin (HA) epitope, and linked to sequences addressing the protein to the bulk cytosol (AEQcyt [70] ) and mitochondrial matrix (AEQmit [71] ), respectively. The transgene plasmids (pLV-AEQmit and pLV-AEQcyt) codifying for AEQmit and AEQcyt were generated by using an AEQ mutant with reduced Ca 2+ affinity allowing [Ca 2+ ] measurements up to hundreds of μM [72] , while a chimeric construct of WT AEQ was used to generate the lentiviral vector for AEQcyt [73] . To obtain lentiviral particles, HEK-293 T cells were seeded onto 100 mm-diameter Petri dishes at ∼40% confluence. 24 h after plating, cells were co-transfected, by means of calcium-phosphate procedure, with one of the transgene plasmids (pLV-AEQmit or pLV-AEQcyt) and V. Basso et al. Pharmacological Research 138 (2018) [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] the packaging plasmids pMDLg/pRRE, pMD2.VSVG, pRSV-Rev. After 10 h, the transfection medium was replaced with fresh culture medium. After 72 h, the HEK-293 T culture medium was collected and viral particles were harvested by ultracentrifugation (50,000×g, 2 h) and resuspended in phosphate buffered saline (PBS; 140 mM NaCl, 2 mM KCl, 1.5 mM KH2PO4, 8 mM Na2HPO4, pH 7.4). Lentiviral stock infectivity was estimated by anti-HA immunocytochemistry as described in Lazzari et al. [74] . All procedures for the production and use of lentiviral particles were performed in a biosafety level-2 environment.
Lentiviral production and cell transduction
Measurements of mitochondrial and cytosolic Ca 2+ fluxes
Cells were incubated (1 h, 37•C, 5% CO2) with the prosthetic group coelenterazine (5 μM, Santa Cruz Biotechnology, cat. n. sc-205904) in step with KRB-CaCl 2 , fibroblasts were stimulated with a mixture of 100 μM ATP and 100 μM histamine dissolved in KRB-CaCl 2 . The experiments were terminated by cell permeabilization with digitonin (100 μM, Sigma) in Ca 2+ -rich solution (10 mM CaCl 2 in H 2 O). AEQ light emission was collected by means of an in-house built luminometer, equipped with a low-noise photo-multiplier coupled by an A/D board to a computer-assisted acquisition system, with a 1 Hz sampling rate [75] . This allowed the calibration of the recorded light signal to the total AEQ content. Conversion of light signal into Ca 2+ concentration was performed as described in Brini et al. [70] and Montero et al. [76] .
Molecular biology
pEYFP-ER (ER YFP), mRFP, pCB6-Myc-Mfn2 (Mfn2 WT) were previously described (de Brito and Scorrano [8] Table 1) using QuikChange II XL Site-Directed Mutagenesis Kit (Agilent). HAUbiquitin (HA-Ub) was obtained from Addgene. FRET based Mito-ER Linker probe (FEMP) and mitochondrial low-affinity aequorin (mtAEQ mut) were previously described [29, 72] .
Parkin siRNA and MFN RNAi treatment
Parkin siRNA was transfected using Oligofectamine ™ reagent (Invitrogen) and 100 nM of siRNA for each treatment following manufacturer instructions. The same amount of scrambled siRNA was used as control. For Parkin knockdown, cells were incubated with siRNA for at least 48 h. For RNA interference, cells were transfected with Parkin siRNA HSS107593 (Invitrogen). Double-stranded RNAs (dsRNAs) were prepared using the MEGAscript kit (Ambion) according to the manufacturer's instructions. Primers used to generate dsRNAs contained a T7 promoter sequence at the 5′ end (MFN forward primer 5′-GGAACCTCTTTATTCTCTAT-3′ and reverse primer 5′-GGTTTGCTTTGCCCCAACAT-3′). A total of 1 million S2R + cells were plated on a six-well plate and treated with 15 μg dsRNA probe in serum-free medium. One hour after probe treatment, complete medium was added to the wells, and cells were cultured for 2 days before being transfected. 
Immunoblotting
MEFs were washed with phosphate-buffered saline (PBS) and scraped off using plastic cell scraper in PBS. The cells were centrifuged at 3000 rpm at 4°C for 5 min. The supernatant was discarded and the pellet resuspended in appropriate volume of modified RIPA buffer (50 mM Tris−HCl, pH 7.4; 1% TritonX; 0.5% Na-deoxycholate; 0.1% SDS; 150 mM NaCl; 2 mM EDTA; 50 mM NaF), upon addition of fresh protease Inhibitor Cocktails (PIC), 50μM MG132 and 10 mM NEthylmaleimide (NEM; a deubiquitinase inhibition). The cells were incubated in ice for 30 min. and vigorously mixed every 10 min. and were centrifuged at 4000 rpm for 10 min. at 4°C and the supernatant was transferred to new tube.
SR2+ cells protein lysate was obtained following incubation with a buffer composed of: 50 mM Tris−HCl, 150 mM NaCl, 1% Triton X, 2 mM EGTA, 1 mM MgCl2 with in addition 10% glycerol, PIC (100X), 10 mM NEM and 50 μM MG132. Cells were centrifuged at 4000 rpm for 10 min. at 4°C and the supernatant was transferred to new tube.
Protein content was quantified using the Pierce™ BCA Protein Assay Kit (Thermo Scientific™).
NuPAGE™ LDS Sample Buffer (4X) (Invitrogen™) and 2-Mercaptoethanol (SIGMA) were added to the samples and proteins were boiled at 95°C for 10 min.. Proteins were loaded in ExpressPlus™ PAGE Gel,10 × 8, 8% (GenScript) or NuPAGE™ 3-8% Tris-Acetate Protein Gels, 1.0 mm (Invitrogen™) and separated using a constant voltage of 100 mV for the appropriate time. After electrophoresis run, proteins were transferred from the gel matrix to Polyvinylidene difluoride (PVDF) membrane (Thermo Fisher Scientific) applying a constant voltage of 100 mV for 2 h at 4°C. The membrane was saturated upon incubation with 5% milk in T-BST (mixture of tris-buffered saline and Tween 20) for 1 h. Proteins were probed using the following antibodies: α-Flag (1:1000; Cell Signaling Technology: 2368S), α-Mfn2 (1:1000; Abnova: H00009927-M03), α-PINK1 (1:500; Novus Biologicals: BC100-494), α-HA (1:1000; Cell Signaling Technology: 3724).
Immunoprecipitation (IP)
MEFs (about 500 000 cells) were plated in a 100 mm dish and the day after were transfected with the Mfn2 WT or the Mfn2 mutants and HA-Ub. 12 or 24 h later, cells were lysed with a buffer composed of: 50 mM Tris−HCl, 150 mM NaCl, 1% Triton X, 2 mM EGTA, 1 mM MgCl2 with in addition 10% glycerol, PIC (100X), 10 mM NEM and 50μM MG132. Protein extract (250μg-1 mg) was incubated with 10 μl of protein A agarose beads (Roche), previously balanced in lysis buffer, for 30 min. at 4°C on the wheel (pre-cleaning). In parallel 30 μl of balanced beads were incubated with 1 μg of α-Mfn2 (Abcam: ab56889) or without the antibody (negative control) for 1 h and half at 4°C on wheel in 70 μl of lysis buffer. Pre-cleaning beads were centrifugated at 4000 rpm for 5 min. and the supernatant was incubated overnight at 4°C with antibody-conjugated beads. The day after the mix was centrifugated and the supernatant was discarded. Beads were washed 3 times for 10 min. at 4°C with lysis buffer and boiled for 10 min. at 95°C in 30-50 μl Laemmli loading buffer 2X (Laemmli 4X: Tris HCL 300 μM, pH 6.8; SDS 300 μM; Sucrose 1,4 M; Beta mercaptoethanol 8%;+ Bromophenol blue). Supernatant was recovered upon maximum speed centrifugation and analyzed by western blotting in NuPAGE™ 3-8% Tris-Acetate Protein Gels. For FRET imaging about 1200-1800 MEFs cells were seeded on 384 well plate (Perkin Elmer). After 12 h cells were transfected with FEMP probe and the indicated plasmids (ratio 1:3) using Genjet in Vitro DNA Transfection Reagent and analyzed using Perkin Elmer Operetta HighContent Imaging System objective 20X after 12 or 24 h. FEMP probe is targeted to the mitochondrial outer membrane (OMM) (targeting sequence mAKAP1 connected to YPF fluorescent protein) and ER (targeting sequence Sac1 connected to CFP fluorescent protein) and contains a self-leaving Tav2 A peptide, which undergoes autocleavage releasing YFP and CFP. FRET intensity is inversely proportional to the distance between the two fluorophores that are appropriately targeted to the two compartments. In the FEMP probe, OMM and ER targeting sequence are coupled with the two components of the FKBP-FRP heterodimerization system that allows covalent linkage between ER and mitochondria upon rapamycin administration. ER-mitochondria juxtaposition can therefore be correlated to FRET intensity and rapamycin treatment allows heterodimerization between adjacent FKBP and FRB domains to maximize FRET intensity. The basal FRET level (FRET basal) was obtained using ex 410-430 and em 460-500 for CFP and ex 490-510 and em 520-560 for YFP while YFP FRET was obtained using ex 410-430 and em 520-560. The maximum FRET intensity (FRETmax) was measured after treatment with 100 μM Rapamycin for 15 min, on fixed cells in PBS (1% Formaldehyde for 10 min.). The images were analyzed using Perkin Elmer Harmony 3.5 image software. The YFP channel was used to mark the ROI (Fcell) and a second bonder, around each ROI, was plotted to measure and subtract the background intensity (Fbg). FRETbasal and FRETmax were calculated as: FYFPFRETcell-FYFPFRETbg)/(FCFPcell-FCFPbg). The FRET Ratio (ΔR/R) is (FRETmax-FRETbasal)/FRETbasal. For FRET imaging of the human fibroblasts about 1800 cells were seeded on 384 well plate (Perkin Elmer). After 24 h cells were transfected with FEMP using Transfection Reagent PEI and analyzed using Perkin Elmer Operetta High-Content Imaging System objective 20X after 12 h.
Human fibroblast from skin biopsy (50.000 cells) were plated on 24 mm round glass coverslips and after 12 h for mitochondria analysis the cells were treated with 1 μ M of Tetramethylrhodamine methyl ester (TMRM) and 10 nM cyclosporin H in HBSS for 20 min. at 37°C or transfected with ER-YFP for 12 h with PEI for ER analysis. Images were acquired using an UPlanSApo 40X/1.00 objective (iMIC Adromeda) upon excitation with 561 or 488 lasers. The 60 z-axis images separated by 0.2 μm were analysis using Volocity 6.3 software to obtain quantitative analysis of the mitochondrial volume, surface area, skeletal length, skeletal diameter. The number of cells per genotype that have been assessed for morphological analysis is minimum 200 per genotype and the average number of mitochondria that have been analysed is 50 per cell. The aspect ratio (AR) was calculated by dividing the mitochondrial skeletal length by the mitochondrial skeletal diameter.
Bioinformatic analysis
Protein sequences of MFN2_HUMAN (O95140), MFN2_MOUSE (Q80U63) and MARF_DROME (Q7YU24) were obtained from database Protein (UniProt). The alignment was performed using MultAlin software.
Aequorin measurement
MEFs were grown on 13 mm round glass coverslips at 50-60% of confluence and co-transfected with the indicated constructs and mitochondrial low affinity aequorin (mtAEQ mut). Cells were incubated for 1.5 h at 37°C in DMEM 1% FBS after being reconstituted with 5 μM coelenterazine wt (invitrogene). 
Electron microscopy
Cells cultured in 24 well plate were fixed in 2% paraformaldehyde, 2.5% gluteraldehyde for 1 h/overnight. After rinsing in 0.1 M cacodylate buffer with 1% tannic acid, samples were post-fixed in 1:1 2% OsO 4 and 0.2 M cacodylate buffer for 1 h. Samples were rinsed, dehydrated in an ethanol, and embedded by using Epon. Ultrathin sections were examined using a transmission electron microscope. The number of contacts that have been analysed for ultrastructure is a minimum of 200 contacts per condition.
Fly stocks and breeding condition
Fly lines were grown on standard cornmeal medium and were maintained at 23°C, 70% relative humidity, on a 12-h light:12-h dark cycle. The UAS mitoGFP/TM6B and UAS KDELGFP/TM6B were obtained from the lab of Prof. Daga, Department of Pharmaceutical and Pharmacological Sciences, University of Padova. The mito-ER syntetic linker, created by Csordás, consists of a monomeric fluorescent protein (mRFP) fused to the OMM targeting sequence of mAKAP1 at the N terminus and fused to the ER targeting sequence of yUBC6 at the C terminus [43] . The construct was cloned into a fly vector (pUAST) and two fly lines expressing different levels of the tethering construct were generated by random insertion into a white1118 − background or PINK1 mutant (KO) background (PINK1 B9 /FM7): UAS-mito-mRFP-ER TH / TM6B (TH, high expression of tether) and UAS-mito-mRFP-ER ™ /TM6B (TM, mild expression of tether). In order to activate neuronal expression of the tethering construct, flies were crossed with nSyb-Gal4/ TM6B, neuronal Synaptobrevin-expressing flies obtained from the Bloomington stock center. PINK1 mutant (KO) flies (PINK1B9/FM7) [24] were a kind gift of Dr. Alexander Whitworth.
Mounting and imaging of fly wing
Flies at 3-5 days of age were fixed with 4% of paraformaldehyde (PFA) for 2 h at room temperature on a rotating wheel and then washed 3 times for 10 min with PBS. The whole wings were cut with CastroViejo Scissors, mounted on 24 mm round glass coverslips with a small amount of ProLong™ Gold Antifade Mountant and subsequently covered with another 12 mm round glass coverslip which was fixed with nail polish. The images were acquired using an UPlanSApo 20X/0.75 objective (iMIC Adromeda) after the excitation with a 561 laser. The quantification of the RFP signal was performed counting the spots using ImageJ along 150 μm of length of the L1 vein neural bundle [48] from the intersection of the L2 vein to proximal side of the wing flies.
Climbing assay
The climbing test was performed at 3 days of age at the same time of the day with male flies of the indicated genotypes. 10 flies for each V. Basso et al. Pharmacological Research 138 (2018) [43] [44] [45] [46] [47] [48] [49] [50] [51] [52] [53] [54] [55] [56] genotype were transferred in a plastic cylinder of 12 cm of length and 5 cm of diameter, marked with a line at 6 cm from the bottom of the tube. Flies were tapped to the bottom of the tube and the number of flies that successfully climbed across the 6 cm line in 10 s was counted. Fifteen separate and consecutive trials were performed for each experiment, and the results were averaged. 50 flies for each genotype were analyzed. The results were expressed as percentage of climbing flies.
Eggs-to-adults viability
The assay was performed to analyze eggs-to-adults viability of the tethering TM and TH flies compared to WT flies. For each lines (WT, WT TM and WT TH) 10 virgin females were crossed with 10 males nSybGal4/TM6B on a plate with sugar yeast fruit medium. The day after, adults were removed and after 3 days eggs were counted. Next the medium with eggs was added to the tube with standard cornmeal medium. After 5 and 10 days from egg laying, the number of pupae and the number of male adults were counted. To analyze the eggs-to-pupae viability the number of pupae was divided by the number of eggs for each genotype and the resulting value was normalized to control (WT). In order to address the larvae-to-adults viability, the number of male adults was divided by the total number of pupae and expressed as percentage.
Statistics
Data were presents as mean ± SEM from at least three independent experiments. Statistical significance was determined using Unpaired ttest and p values are indicated (GraphPad software).
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